AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 26-50/52

Authors: YANAGI K YAMASHITA S HIRAOKA H ISHIGAMI M KIHARA S HIRANO K SAKAI N NOZAKI S FUNAHASHI T KAMEDATAKEMURA K KUBO M TOKUNAGA K MATSUZAWA Y
Citation: K. Yanagi et al., INCREASED SERUM REMNANT LIPOPROTEINS IN PATIENTS WITH APOLIPOPROTEIN E7 (APO E-SUITA), Atherosclerosis, 131(1), 1997, pp. 49-58

Authors: ISHIGAMI M YAMASHITA S SAKAI N HIRANO KI ARAI T MARUYAMA T TAKAMI S KOYAMA M KAMEDATAKEMURA K MATSUZAWA Y
Citation: M. Ishigami et al., HIGH-DENSITY-LIPOPROTEINS FROM PROBUCOL-TREATED PATIENTS HAVE INCREASED CAPACITY TO PROMOTE CHOLESTEROL EFFLUX FROM MOUSE PERITONEAL-MACROPHAGES LOADED WITH ACETYLATED LOW-DENSITY LIPOPROTEINS, European journal of clinical investigation, 27(4), 1997, pp. 285-292

Authors: MARUYAMA T SHIZUYA Y SAKAI N HIRANO KI ARAI T ISHIGAMI M MATSUZAWA Y
Citation: T. Maruyama et al., MUTATIONAL ANALYSIS OF HYPERALPHALIPOPROTEINEMA (HALP) IN THE JAPANESE - CHOLESTEROL ESTER TRANSFER PROTEIN-DEFICIENCY CONTRIBUTES TO APPROXIMATELY 60-PERCENT OF MARKED HALP-, Circulation, 96(8), 1997, pp. 597-597

Authors: CHIBA J INOUE K CHIBA C ISHIGAMI M SUGAWARA S
Citation: J. Chiba et al., BIOCHEMICAL AND MORPHOLOGICAL ANALYSES OF HUMAN MACROPHAGES ACTIVATEDBY HUMAN RED-CELLS, Journal of orthopaedic rheumatology, 9(4), 1996, pp. 217-221

Authors: YAMAZAKI M TOKUI T ISHIGAMI M SUGIYAMA Y
Citation: M. Yamazaki et al., TISSUE-SELECTIVE UPTAKE OF PRAVASTATIN IN RATS - CONTRIBUTION OF A SPECIFIC CARRIER-MEDIATED UPTAKE SYSTEM, Biopharmaceutics & drug disposition, 17(9), 1996, pp. 775-789

Authors: ESUMI K ISHIGAMI M NAKAJIMA A SAWADA K HONDA H
Citation: K. Esumi et al., CHEMICAL TREATMENT OF CARBON NANOTUBES, Carbon, 34(2), 1996, pp. 279-281

Authors: HIRANO K YAMASHITA S KUGA Y SAKAI N NOZAKI S KIHARA S ARAI T YANAGI K TAKAMI S MENJU M ISHIGAMI M YOSHIDA Y KAMEDATAKEMURA K HAYASHI K MATSUZAWA Y
Citation: K. Hirano et al., ATHEROSCLEROTIC DISEASE IN MARKED HYPERALPHALIPOPROTEINEMIA - COMBINED REDUCTION OF CHOLESTERYL ESTER TRANSFER PROTEIN AND HEPATIC TRIGLYCERIDE LIPASE, Arteriosclerosis, thrombosis, and vascular biology, 15(11), 1995, pp. 1849-1856

Authors: RITCHIE LD SUGAWARA S ISHIGAMI M SATOH Y SUZUKI K
Citation: Ld. Ritchie et al., LOCAL-ACTION TRANSCUTANEOUS FLURBIPROFEN (FLURBIPROFEN LAT) IN THE TREATMENT OF ACUTE MUSCULOSKELETAL CONDITIONS - A REVIEW OF EUROPEAN ANDJAPANESE EXPERIENCE, Journal of orthopaedic rheumatology, 8(3), 1995, pp. 134-139

Authors: ISHIGAMI M TOKUI T KOMAI T TSUKAHARA K YAMAZAKI M SUGIYAMA Y
Citation: M. Ishigami et al., EVALUATION OF THE UPTAKE OF PRAVASTATIN BY PERFUSED-RAT-LIVER AND PRIMARY CULTURED RAT HEPATOCYTES, Pharmaceutical research, 12(11), 1995, pp. 1741-1745

Authors: TOKUI T TAKATORI T SHINOZAKI N ISHIGAMI M SHIRAISHI A IKEDA T TSURUO T
Citation: T. Tokui et al., DELIVERY AND CYTOTOXICITY OF RS-1541 IN ST-4 HUMAN GASTRIC-CANCER CELLS IN-VITRO BY THE LOW-DENSITY-LIPOPROTEIN PATHWAY, Cancer chemotherapy and pharmacology, 36(1), 1995, pp. 1-6

Authors: LOO Y SHIN M YAMASHITA Y ISHIGAMI M SASAKI M SANO K UMEZAWA C
Citation: Y. Loo et al., EFFECT OF FEEDING CLOFIBRATE-CONTAINING DIET ON THE HEPATIC NAD(+) LEVEL IN RATS, Journal of nutritional science and vitaminology, 41(3), 1995, pp. 341-347

Authors: MIZUIRI S HEMMI H INOUE A YOSHIKAWA H TANEGASHIMA M FUSHIMI T ISHIGAMI M AMAGASAKI Y OHARA T SHIMATAKE H HASEGAWA A
Citation: S. Mizuiri et al., ANGIOTENSIN-CONVERTING ENZYME POLYMORPHISM AND DEVELOPMENT OF DIABETIC NEPHROPATHY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Nephron, 70(4), 1995, pp. 455-459

Authors: NOZAKI S KASHIWAGI H YAMASHITA S NAKAGAWA T KOSTNER B TOMIYAMA Y NAKATA A ISHIGAMI M MIYAGAWA JI KAMEDATAKEMURA K KURATA Y MATSUZAWA Y
Citation: S. Nozaki et al., REDUCED UPTAKE OF OXIDIZED LOW-DENSITY LIPOPROTEINS IN MONOCYTE-DERIVED MACROPHAGES FROM CD36-DEFICIENT SUBJECTS, The Journal of clinical investigation, 96(4), 1995, pp. 1859-1865

Authors: SAKAI N YAMASHITA S HIRANO K MENJU M ARAI T KOBAYASHI K ISHIGAMI M YOSHIDA Y HOSHINO T NAKAJIMA N KAMEDATAKEMURA K MATSUZAWA Y
Citation: N. Sakai et al., FREQUENCY OF EXON-15 MISSENSE MUTATION (442D-G) IN CHOLESTERYL ESTER TRANSFER PROTEIN GENE IN HYPERALPHALIPOPROTEINEMIC JAPANESE SUBJECTS, Atherosclerosis, 114(2), 1995, pp. 139-145

Authors: SAKAI N YAMASHITA S HIRANO KI ISHIGAMI M ARAI T KOBAYASHI K FUNAHASHI T MATSUZAWA Y
Citation: N. Sakai et al., DECREASED AFFINITY OF LOW-DENSITY-LIPOPROTEIN (LDL) PARTICLES FOR LDLRECEPTORS IN PATIENTS WITH CHOLESTERYL ESTER TRANSFER PROTEIN-DEFICIENCY, European journal of clinical investigation, 25(5), 1995, pp. 332-339

Authors: ARAI T YAMASHITA S HIRANO KI SAKAI N KOTANI K FUJIOKA S NOZAKI S KENO Y YAMANE M SHINOHARA E ISLAM AHMW ISHIGAMI M NAKAMURA T KAMEDATAKEMURA K TOKUNAGA K MATSUZAWA Y
Citation: T. Arai et al., INCREASED PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN IN OBESE SUBJECTS- A POSSIBLE MECHANISM FOR THE REDUCTION OF SERUM HDL CHOLESTEROL LEVELS IN OBESITY, Arteriosclerosis and thrombosis, 14(7), 1994, pp. 1129-1136

Authors: ISHIGAMI M YAMAGUCHI S
Citation: M. Ishigami et S. Yamaguchi, USEFULNESS OF SERUM TROPONIN-T (TNT) FOR PREDICTION OF CARDIAC DEATH IN HEMODIALYSIS (HD) PATIENTS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 455-455

Authors: TAKEDA M ISHIGAMI M SHIMADA A MATSUOKA H NAKAMURA I
Citation: M. Takeda et al., SEPARATION AND PRELIMINARY CHARACTERIZATION OF ACIDIC POLYSACCHARIDESPRODUCED BY ENTEROBACTER SP, Journal of fermentation and bioengineering, 78(2), 1994, pp. 140-144

Authors: TOKUI T TOKUI Y ISHIGAMI M TANZAWA K IKEDA T KOMAI T
Citation: T. Tokui et al., TARGETING OF AN ANTITUMOR AGENT, RS-1541 (PALMITOYL-RHIZOXIN), VIA LOW-DENSITY-LIPOPROTEIN RECEPTOR, International journal of pharmaceutics, 110(3), 1994, pp. 277-283

Authors: ISHIGAMI M
Citation: M. Ishigami, USAGE AND MEANING OF INFORMATION IN JAPAN ESE, Library and Information Science, (32), 1994, pp. 17-41

Authors: ISHIGAMI M YAMASHITA S SAKAI N ARAI T HIRANO K HIRAOKA H KAMEDATAKEMURA K MATSUZAWA Y
Citation: M. Ishigami et al., LARGE AND CHOLESTERYL ESTER-RICH HIGH-DENSITY-LIPOPROTEINS IN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) DEFICIENCY CAN NOT PROTECT MACROPHAGES FROM CHOLESTEROL ACCUMULATION INDUCED BY ACETYLATED LOW-DENSITY LIPOPROTEINS, Journal of Biochemistry, 116(2), 1994, pp. 257-262

Authors: NOZAKI S YAMASHITA S KASHIWAGI H TOMIYAMA Y NAKATA A NAKAGAWA T ISHIGAMI M MIYAGAWA J TAKEMURA K KKURATA Y MATSUZAWA Y
Citation: S. Nozaki et al., THE ROLE OF CD36 ON FOAM CELL FORMATION-REDUCED UPTAKE OF OXIDIZED LDL IN MONOCYTE-MACROPHAGES FROM CD36 DEFICIENT PATIENTS, Circulation, 90(4), 1994, pp. 190-190

Authors: NOZAKI S YAMASHITA S KASHIWAGI H TOMIYAMA Y NAKATA A NAKAGAWA T ISHIGAMI M MIYAGAWA J TAKEMURA K KKURATA Y MATSUZAWA Y
Citation: S. Nozaki et al., THE ROLE OF CD36 ON FOAM CELL FORMATION-REDUCED UPTAKE OF OXIDIZED LDL IN MONOCYTE-MACROPHAGES FROM CD36 DEFICIENT PATIENTS, Circulation, 90(4), 1994, pp. 190-190

Authors: YAMASHITA S HIRANO K ISHIGAMI M ARAI T SAKAI N NAZAKI S TAKEMURA K MATSUZAWA Y
Citation: S. Yamashita et al., MARKED HYPERALPHALIPOPROTEINEMIA (HALP) DUE TO A COMBINED REDUCTION IN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) AND HEPATIC TRIGLYCERIDE LIPASE (HTGL) IS ACCOMPANIED BY ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE (ACD), Circulation, 90(4), 1994, pp. 510-510

Authors: YAMASHITA S HIRANO K ISHIGAMI M ARAI T SAKAI N NAZAKI S TAKEMURA K MATSUZAWA Y
Citation: S. Yamashita et al., MARKED HYPERALPHALIPOPROTEINEMIA (HALP) DUE TO A COMBINED REDUCTION IN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) AND HEPATIC TRIGLYCERIDE LIPASE (HTGL) IS ACCOMPANIED BY ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE (ACD), Circulation, 90(4), 1994, pp. 510-510
Risultati: 1-25 | 26-50 | 51-52